OncorMed, Cancer Research Campaign Technology, Duke University regulatory update

Cancer Research and Duke received U.K. Patent No. 52,307,477 covering the full length coding sequence of the BRCA2 gene, including pharmaceutical compositions, diagnostic methods and a method for pro...